Financing the Response to AIDS in Low- and Middle- Income Countries: International Assistance from Donor Governments in 2011. Kates J, Wexler A, Lief E and Gobet B. (2012).
 |
This report is based on analysis of data provided by the 23 donor government members of the Organisation for Economic Co-operation and Development (OECD)’s Development Assistance Committee (DAC) and the European Union (EU). It includes their combined bilateral assistance and contributions to the Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) and to UNITAID.
|
Report from Expert Consultation on Costing HIV Responses in Asia. UNAIDS RST (2010)
 |
An Expert Consultation on Costing HIV Responses in Asia-Pacific was held from 28 to 29 October 2010 for expert developers and users to assess the usefulness of various costing tools for different purposes, as well as their comparability and complementarities. The meeting outcomes were intended to support the HIV National Strategic Planning process and Global Fund (and other) proposal development at a time when resources are expected to decline, so that countries must prioritize and implement the most cost-effective programmes.
Download publication |
National AIDS Spending Assessment (2008-2009), Mongolia. National Committee on AIDS and UNAIDS. (2010)
 |
In recognition of the severity of the HIV/AIDS pandemic, international organizations, policymakers, and donors have made bold declarations and set targets for curbing the spread of HIV/AIDS, mitigating its impact, and extending treatment access. For example, the Millennium Development Goals (MDGs), defined by the international community to serve as a framework for measuring country development progress, aim to halt and reverse the spread of HIV/AIDS by the year 2015. In addition, in 2001, 189 nations adopted the Declaration of Commitment on HIV/AIDS at the first-ever United Nations General Assembly Special Session (UNGASS) on HIV/AIDS; this Declaration covers 10 priorities, from prevention to treatment to funding, and was designed as a blueprint to meet the HIV/AIDS MDGs. |
| Download Publication |
The World Health Report: Health Systems Financing: The Path to Universal Coverage. WHO (2010)
 |
Promoting and protecting health is essential to human welfare and sustained economic and social development. This was recognized more than 30 years ago by the Alma-Ata Declaration signatories, who noted that Health for All would contribute both to a better quality of life and also to global peace and security.
|
National AIDS Spending Assessment (NASA), 2007-2009, Philippines. (2010)
|
The objective of the NASA report is to track HIV/AIDS spending from 2007 to 2009 from various sources of financing covering both public and external funds. The aim of this initiative is to inform policy-makers, program managers, and the donor community on the magnitude and profile of HIV/AIDS expenditures in the country and guide them in their planning and decisionmaking activities. |
| Download Publication |
Reviewing the Evidence on Effectiveness and Cost-effectiveness of HIV Prevention Strategies in Thailand. Pattanaphesaj J and Teerawattananon Y (2010)
 |
Following universal access to antiretroviral therapy in Thailand, evidence from National AIDS Spending Assessment indicates a decreasing proportion of expenditure on prevention interventions. To prompt policymakers to revitalize HIV prevention, this study identifies a comprehensive list of HIV/AIDs preventive interventions that are likely to be effective and cost-effective in Thailand. Download this publication |
China National AIDS Spending Assessment 2010. Yakusik A, Zhongdan C, Fernández CA, et al. (2012)
 |
Comprehensive information about national spending on AIDS response is crucial for health policy development and evaluation. Dehong Prefecture of Yunnan Province is one of the areas hardest hit by HIV in China. Since 1989, when the first 146 HIV-infected injecting drug users (IDUs) were identified in Dehong, this area with 1.1 million of people reported a cumulative total of 17,590 HIV cases by the end of 2010. Studies conducted suggest that the population prevalence for HIV infections in Dehong Prefecture is estimated to be 1.3%. IDUs make up the majority of the people living with HIV (PLHIV) in Dehong Prefecture, accounting for more than a half of the total number of estimated HIV cases in Dehong with high estimated HIV prevalence. HIV transmission mode has been changing gradually over the recent years from intravenous drug use to heterosexual and homosexual transmission. This study provides a comprehensive overview of the overall level and composition of major investments in national AIDS response in Dehong Prefecture introducing National AIDS Spending Assessment (NASA) as a method for the purpose.
|
| Download Publication |
HIV Spending as a Share of Total Health Expenditure: An Analysis of Regional Variation in a Multi-Country Study. Amico P, Aran C and Avila C (2010)
 |
HIV has devastated numerous countries in sub-Saharan Africa and is a dominant health force in many other Source: Amico P, Aran C, Avila C (2010) HIV Spending as a Share of Total Health Expenditure: An Analysis of Regional Variation in a Multi-Country Study. PLoS ONE 5(9): e12997. doi:10.1371/journal.pone.0012997 Download this publication |
The Effects of Scale on the Costs of Targeted HIV Prevention Interventions among Sex Workers, Men who Have Sex with Men and Transgenders in India. S Chandrashekar, L Guinness, L Kumaranayake, et al (2010)
 |
The India AIDS Initiative (Avahan) project is involved in rapid scale-up of HIV-prevention interventions in high-risk populations. This study examines the cost variation of 107 non-governmental organisations (NGOs) implementing targeted interventions, over the start up (defined as period from project inception until services to the key population commenced) and first 2 years of intervention. Download this publication |
The Long-Run Costs and Financing of HIV/AIDS in Cambodia. Saphonn V, Chhorvann C, Sopheab H, et al (2010)
 |
In many respects, Cambodia has made exceptional progress in addressing HIV/AIDS since it was first detect- ed in 1991. While the estimated number of new infections grew to reach almost 15,500 annually in the early 1990s, it had been reduced to about 2,100 by 2009. Download this publication |
Pages
